Skip to main content

Table 1 Clinicopathological data of patients with non-metastatic ccRCC

From: Clinical significance of prognostic nutritional index (PNI)-monocyte-to-lymphocyte ratio (MLR)-platelet (PLT) score on postoperative outcomes in non-metastatic clear cell renal cell carcinoma

Parameter

Total (n = 164)

Gender (male/female)

99 (60%)/65 (40%)

Age, years (≥ 65/ < 65)

45 (27%)/119 (73%)

Drinking (yes/no)

23 (14%)/141 (86%)

Smoking (yes/no)

51 (31%)/113 (69%)

DM (yes/no)

16 (10%)/148 (90%)

Hypertension (yes/no)

68 (41%)/96 (59%)

Anemia (yes/no)

55 (34%)/109 (66%)

Hypoalbuminemia (yes/no)

10 (6.0%)/154 (94%)

Surgical approach (Partial nephrectomy/ Radical nephrectomy)

22 (13%)/142 (87%)

Renal dysfunction (yes/no)

8 (5.0%)/156 (95%)

Tumor number (> = 2/1)

4 (2.0%)/160 (98%)

Site (left/right)

84 (51%)/80 (49%)

Pathologic T stage (T1/T2/T3/T4)

134 (82%)/17 (10%)/10 (6%)/3 (2.0%)

G grade (1/2/3/4)

99 (60%)/45 (27%)/7 (4.0%)/6 (4.0%)

Tumor necrosis (yes/no)

6 (4.0%)/158 (96%)

Tumor hemorrhage

12 (7.0%)/152 (93%)

Lymphatic and microvascular infiltration

7 (4.0%)/157 (96%)

PNI (> 47.40/ < 47.40)

119 (73%)/45 (27%)

MLR (> 0.31/ < 0.31)

57 (35%)/107 (65%)

PLT (> 245/ < 245)

16 (10%)/148 (90%)

PMP score (0/1/2/3)

7 (4.0%)/24 (15%)/49 (30%)/84 (51%)

  1. ccRCC Clear cell renal cell carcinoma, DM Diabetes mellitus, PNI Prognostic Nutritional Index, MLR Monocyte-to-lymphocyte ratio, PLT Platelet, PMP score PNI-MLR-PLT score